GeneDx Holdings (WGS) Free Cash Flow

Annual FCF

-$185.86 M
+$147.62 M+44.27%

December 31, 2023

Summary

Performance

1-Year Change

+44.27%

3-Year Change

-48.57%

5-Year Change

-443.7%

15-Year Change

-443.7%

WGS Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

7.03%
WGS annual free cash flow is higher than 7.03% of companies in Healthcare sector

High & Low

All-time High

-$34.18 M

3-Year Low

-$333.48 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
WGS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 18, 2025
WGS next annual earnings announcement is scheduled for Feb 18, 2025

OtherWGScash flowmetrics:

Annual CFO

-$180.15 M
WGS annual cash flow from operations is -$180.15 million

Annual CFF

$186.24 M
WGS annual cash flow from financing activities is $186.24 million

Annual CFI

-$43.73 M
WGS annual cash flow from investing activities is -$43.73 million

Annual CAPEX

$5.71 M
WGS annual capital expenditures is $5.71 million

Quarterly FCF

-$5.04 M
+$816.00 K+13.93%

September 30, 2024

Summary

Performance

3-Month Change

+13.93%

1-Year Change

+13.93%

3-Year Change

+91%

5-Year Change

+91%

WGS Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.77%
WGS quarterly free cash flow is higher than 46.77% of companies in Healthcare sector

High & Low

All-time High

-$5.04 M
WGS quarterly free cash flow is currently at an all-time high

3-Year Low

-$92.64 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
WGS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 18, 2025
WGS next earnings announcement is scheduled for Feb 18, 2025

OtherWGScash flowmetrics:

Quarterly CFO

-$4.39 M
WGS quarterly cash flow from operations is -$4.39 million

Quarterly CFF

$13.97 M
WGS quarterly cash flow from financing activities is $13.97 million

Quarterly CFI

-$7.75 M
WGS quarterly cash flow from investing activities is -$7.75 million

Quarterly CAPEX

$646.00 K
WGS quarterly capital expenditures is $646.00 thousand

TTM FCF

-$59.99 M
+$36.30 M+37.70%

September 30, 2024

Summary

Performance

3-Month Change

+37.7%

1-Year Change

+37.7%

3-Year Change

+80.27%

5-Year Change

+80.27%

WGS TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.01%
WGS TTM free cash flow is higher than 27.01% of companies in Healthcare sector

High & Low

All-time High

-$47.20 M

3-Year Low

-$333.48 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
WGS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 18, 2025
WGS next earnings announcement is scheduled for Feb 18, 2025

OtherWGScash flowmetrics:

TTM CFO

-$55.17 M
WGS TTM cash flow from operations is -$55.17 million

TTM CFF

$60.24 M
WGS TTM cash flow from financing activities is $60.24 million

TTM CFI

-$34.48 M
WGS TTM cash flow from investing activities is -$34.48 million

TTM CAPEX

$4.82 M
WGS TTM capital expenditures is $4.82 million

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$185.86 M
WGS annual free cash flow is -$185.86 million

Annual CFO

-$180.15 M
WGS annual cash flow from operations is -$180.15 million

Annual CAPEX

$5.71 M
WGS annual capital expenditures is $5.71 million

WGS Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+44.3%+13.9%+37.7%
3 y3 years-48.6%+91.0%+80.3%
5 y5 years-443.7%+91.0%+80.3%

WGS Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+44.3%at high+94.6%at high+82.0%
5 y5-year-443.7%+44.3%at high+94.6%-27.1%+82.0%
alltimeall time-443.7%+44.3%at high+94.6%-27.1%+82.0%

GeneDx Holdings Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.04 M(-13.9%)
-$59.99 M(-37.7%)
Jun 2024
-
-$5.86 M(-65.3%)
-$96.29 M(-34.4%)
Mar 2024
-
-$16.86 M(-47.7%)
-$146.69 M(-21.1%)
Dec 2023
-$185.86 M(-44.3%)
-$32.23 M(-22.0%)
-$185.86 M(-15.9%)
Sep 2023
-
-$41.34 M(-26.5%)
-$221.12 M(-18.8%)
Jun 2023
-
-$56.26 M(+0.4%)
-$272.42 M(-10.4%)
Mar 2023
-
-$56.02 M(-17.0%)
-$304.09 M(-8.8%)
Dec 2022
-$333.48 M
-$67.49 M(-27.1%)
-$333.48 M(+2.4%)
Sep 2022
-
-$92.64 M(+5.3%)
-$325.66 M(+5.9%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$87.94 M(+3.0%)
-$307.58 M(+23.3%)
Mar 2022
-
-$85.41 M(+43.1%)
-$249.43 M(+18.1%)
Dec 2021
-$211.22 M(+68.8%)
-
-
Dec 2021
-
-$59.68 M(-20.0%)
-$211.22 M(+39.4%)
Sep 2021
-
-$74.56 M(+150.3%)
-$151.54 M(+96.8%)
Jun 2021
-
-$29.78 M(-36.9%)
-$76.98 M(+63.1%)
Mar 2021
-
-$47.20 M
-$47.20 M
Dec 2020
-$125.10 M(+266.0%)
-
-
Dec 2019
-$34.18 M
-
-

FAQ

  • What is GeneDx Holdings annual free cash flow?
  • What is the all time high annual FCF for GeneDx Holdings?
  • What is GeneDx Holdings annual FCF year-on-year change?
  • What is GeneDx Holdings quarterly free cash flow?
  • What is the all time high quarterly FCF for GeneDx Holdings?
  • What is GeneDx Holdings quarterly FCF year-on-year change?
  • What is GeneDx Holdings TTM free cash flow?
  • What is the all time high TTM FCF for GeneDx Holdings?
  • What is GeneDx Holdings TTM FCF year-on-year change?

What is GeneDx Holdings annual free cash flow?

The current annual FCF of WGS is -$185.86 M

What is the all time high annual FCF for GeneDx Holdings?

GeneDx Holdings all-time high annual free cash flow is -$34.18 M

What is GeneDx Holdings annual FCF year-on-year change?

Over the past year, WGS annual free cash flow has changed by +$147.62 M (+44.27%)

What is GeneDx Holdings quarterly free cash flow?

The current quarterly FCF of WGS is -$5.04 M

What is the all time high quarterly FCF for GeneDx Holdings?

GeneDx Holdings all-time high quarterly free cash flow is -$5.04 M

What is GeneDx Holdings quarterly FCF year-on-year change?

Over the past year, WGS quarterly free cash flow has changed by +$816.00 K (+13.93%)

What is GeneDx Holdings TTM free cash flow?

The current TTM FCF of WGS is -$59.99 M

What is the all time high TTM FCF for GeneDx Holdings?

GeneDx Holdings all-time high TTM free cash flow is -$47.20 M

What is GeneDx Holdings TTM FCF year-on-year change?

Over the past year, WGS TTM free cash flow has changed by +$36.30 M (+37.70%)